Neil Diamond Announces Retirement from Concert Touring; Australian and New Zealand Tour Dates Cancelled
Legendary singer, songwriter and performer Neil Diamond today announced his retirement from touring due to his recent diagnosis of Parkinson’s disease. The onset of the disease has made it difficult to travel and perform on a large scale basis but will allow Mr. Diamond to continue his writing, recording and development of new projects. Based on his doctors’ advice, the third leg of Diamond’s 50th Anniversary tour, set to land in Australia and New Zealand this March, has been cancelled.
“It is with great reluctance and disappointment that I announce my retirement from concert touring. I have been so honored to bring my shows to the public for the past 50 years,” said Neil Diamond. “My sincerest apologies to everyone who purchased tickets and were planning to come to the upcoming shows.
I plan to remain active in writing, recording and other projects for a long time to come.
My thanks go out to my loyal and devoted audiences around the world. You will always have my appreciation for your support and encouragement. This ride has been ‘so good, so good, so good’ thanks to you.”
The Australia and New Zealand leg of the 50th Anniversary tour (announced by TEG Dainty in November, 2017) was scheduled to visit a number of outdoor stadiums as well as arena and winery shows in Australia and New Zealand. This would have been the third leg of the 50th Anniversary tour with Diamond selling out shows in the U.S. and Europe throughout 2017.
In making the announcement, Paul Dainty, President and CEO of TEG Dainty, stated: “I am devastated and saddened to hear the news of Neil’s illness and his retirement from touring. I have had the honour of promoting Neil’s numerous tours in Australia and New Zealand, he is one of the world’s greatest artists and we and his thousands and thousands of fans here will miss seeing him tour down under.”
On January 24th, Diamond will celebrate his 77th birthday and on January 28th The Recording Academy will honor him with its prestigious Lifetime Achievement Award.
REFUND INFORMATION
Credit & Debit Card - Tickets purchased by credit or debit card will be refunded in full (including your ticket insurance premium, if relevant) and you do not need to take any action. Please allow up to 10 working days for the refund to appear in your account.
Cash & Eftpos - Patrons who purchased tickets with cash or EFTPOS, Ticketek will be in contact to arrange a refund.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180122006724/en/
Contact information
DRPR
Deborah Radel
deborah@drpr.us
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Agendia to Present FLEX Study Data on Impact of BluePrint® at ESMO Breast Cancer 20256.5.2025 09:00:00 EEST | Press release
Agendia®, Inc., today announced that new data from its ongoing FLEX Study will be presented at the upcoming ESMO BreastCancer 2025 congress taking place May 14-17 in both Munich, Germany and virtually. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250505212759/en/ The FLEX Study (NCT03053193) is a prospective real-world evidence, observational breast cancer study designed to correlate whole transcriptome gene expression in early-stage breast cancer with clinical outcomes, and to evaluate how genomic insights can inform treatment decisions in early-stage breast cancer. In this analysis, researchers examined the impact of BluePrint, Agendia’s 80-gene molecular subtyping assay, on pathological complete response (pCR) rates and chemotherapy (CT) decision-making in patients with hormone receptor-positive (HR+), HER2-negative tumors classified as High Risk by MammaPrint. BluePrint further stratified these tumors into Basal or Lum
Owkin Launches K Navigator, a Ground-breaking Agentic Co-pilot to Speed up Breakthroughs in Biomedical Research by 20x6.5.2025 07:15:00 EEST | Press release
Owkin, a leading agentic AI company, has launched K Navigator, an AI-powered research co-pilot designed to revolutionize biomedical science. K Navigator is an agentic playground where researchers can explore, refine, and validate hypotheses, accelerating the quality and pace of their discoveries. With K Navigator, Owkin moves closer to its vision of developing the world’s first Biological Artificial Superintelligence (BASI). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250505282917/en/ K Navigator home screen. A single natural language interface - K Navigator enables users to explore and visualize data, refine questions, and uncover insights with ease. It accelerates literature reviews across 26.5 million scientific articles, reveals unexplored and unpublished research areas, and delivers more accurate analysis, drawing on 19 biomedical databases featuring thousands of patients. Exclusive access to cutting-edge spatial tra
NIKE, Inc. Announces Senior Leadership Changes to Accelerate Growth and Drive Win Now Action Plan5.5.2025 23:15:00 EEST | Press release
NIKE, Inc. (NYSE:NKE) announced a series of strategic changes to its Senior Leadership Team (SLT), elevating experienced leaders to accelerate progress against its Win Now action plan to position the company for future growth. Elliott Hill, President and CEO, NIKE, Inc. and Heidi O’Neill, President of Consumer, Product, and Brand, have decided the Consumer, Product, and Brand leadership will now be divided into three distinct areas: Consumer and Sport, Marketing, and Product Creation, inclusive of Innovation and Design. These roles will now report directly to Hill. As a result of these changes O’Neill has decided to retire from Nike after 26 years. She will continue to serve in an advisory capacity until September 2025. “For nearly three decades, Heidi has been a true champion for Nike, for sport and for athletes across the globe. Her vision and dedication over the years have left an indelible mark on Nike and created an impact on the world of sport,” said Hill. “Among Heidi’s many suc
LR Health & Beauty Once Again Demonstrates Its Expertise in Aloe Vera5.5.2025 17:24:00 EEST | Press release
LR Health & Beauty has been synonymous with the best Aloe Vera quality on the market for over 20 years, and continuously invests in new product innovations to take full advantage of the plant's range of beneficial properties. The majority of the over 60 products are developed and produced directly at the company headquarters in Ahlen. LR has now made a decisive breakthrough in skin care cosmetics with its unique combination of pure Aloe Vera leaf gel and fermented Aloe Vera. The care products with the highest Aloe Vera content therefore not only work in the upper and middle layers of the skin, but also unleash the full potential of Aloe Vera in the deeper layers. The effectiveness of this LR Aloe Via Magic Power Duo has been confirmed by the dermatological institute, Dermatest. All the products tested based on a combination of Aloe Vera Gel and fermented Aloe were awarded the 5-star "very good" seal by Dermatest. The test results* show increased moisture retention (up to 176%), improve
MultiBank Group Signs Strategic Partnership With MAG to Tokenize $3 Billion Real Estate Assets5.5.2025 17:09:00 EEST | Press release
MultiBank Group, the world’s largest financial derivatives institution based in Dubai has signed a historic $3 billion tokenization agreement with MAG, the leading real estate developer in the UAE, and Mavryk, a leading blockchain innovator — marking the largest real-world asset (RWA) tokenization initiative globally to date. The initiative highlights the imminent launch of $MBG, the utility token at the core of MultiBank’s next-generation digital finance ecosystem. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250505317631/en/ MultiBank Group Signs Strategic Partnership With MAG to Tokenize $3 Billion Real Estate Assets The partnership will bring MAG’s high-value real estate developments — The Ritz-Carlton Residences, Dubai, Creekside, which is part of the Keturah Resort, and Keturah Reserve — onto the blockchain, making them available to global investors via MultiBank.io’s fully regulated RWA marketplace. Once launched, h
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom